3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
3
Prostatic Neoplasms
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Pancreatic Neoplasms
2
Breast Neoplasms
2
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Prostate Adenocarcinoma
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Male Urogenital Diseases
1
Lymphedema
1
Lung Neoplasms
1
Gallbladder Neoplasms
1
Financial Stress
1
Female Urogenital Diseases
1
Endometrial Neoplasms
1
Encopresis
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Carcinoma In Situ
1
Interventions
Oxaliplatin
14
Leucovorin
12
Fluorouracil
12
Cetuximab
10
Bevacizumab
9
pembrolizumab
7
Specimen Handling
7
Nivolumab
6
Magnetic Resonance Spectroscopy
6
Irinotecan
5
encorafenib
4
Pemetrexed
4
Gemcitabine
4
Cisplatin
4
fludarabine
3
cemiplimab
3
Laparoscopy
3
Folfox protocol
3
Early Intervention, Educational
3
Cyclophosphamide
3
Carboplatin
3
Capecitabine
3
Biopsy
3
trifluridine tipiracil drug combination
2
pertuzumab
2
durvalumab
2
dehydroftorafur
2
aldesleukin
2
X-Rays
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Radiation Dose Hypofractionation
×
90 days
×
Clear all
No trials found.